A heart failure event occurred in 63 patients (20.9%) in the Sema-CKM Group and 121 (40.1%) in the Control-CKM Group (OR: 0.80; 95%CI: 0.62-0.98; <i>p</i> < 0.01). This evidence concerns the gene CKM and heart failure.